Resources - Action Santé Mondiale

Cooperation for development EU, Immunization, Promoting transparent and needs-driven EU R&D policies, Research and Development

People or Profits: how will the European Parliament vote on vaccine equity?

On June 9, the European Parliament will have the chance to vote in favor of using a tool that will allow us all to end…

actionsantemondiale8 June 2021

Global Health Summit / Global Health Advocates reaction to the draft Declaration

Press release

Covid-19, UHC

Global Health Summit / Global Health Advocates reaction to the draft Declaration

Press Release GHA welcomes the up-coming Rome Declaration and the efforts of G20 leaders to set principles and guiding commitments to serve as orientation for…

actionsantemondiale20 May 2021

A watershed moment in the global fight against the pandemic: so far a strong opponent, now the United States supports the lifting of patents on COVID19 vaccines.

Press release

Covid-19, Fight against pandemics, Research and Development

A watershed moment in the global fight against the pandemic: so far a strong opponent, now the United States supports the lifting of patents on COVID19 vaccines.

Press Release The statement provoked a series of reactions from many high-level officials from European governments, including Germany*, Spain, Italy, Ireland, Sweden and the Netherlands.…

actionsantemondiale6 May 2021

One year anniversary of ACT-Accelerator: How can we guarantee an equitable and efficient response to the global COVID19 crisis?

Report

Covid-19, Immunization

One year anniversary of ACT-Accelerator: How can we guarantee an equitable and efficient response to the global COVID19 crisis?

On 15 April 2020, on the occasion of the first anniversary of ACT-Accelerator, Global Health Advocates organised an online event to discuss France’s and the…

actionsantemondiale29 April 2021

Press release

Covid-19

Nearly 400 MEPs and MPs Join Chorus of Voices Calling for a TRIPS Waiver on COVID-19 Vaccines

Press release The European Commission and European Union (EU) Member States continue to ignore growing calls for a patent waiver that would increase global production…

actionsantemondiale27 April 2021

Recommendation

Covid-19

Statement of Global Health Advocates for the Global Health Summit: A political landmark for bold progress in the COVID-19 response and achieving global health equity

Position paper While it is important to learn from our mistakes and begin preparing for the next health crisis, we must not forget that we…

actionsantemondiale27 April 2021

Promoting transparent and needs-driven EU R&D policies, Research and Development

Innovative Health Initiative – what’s in it for society?

The European Commission has proposed nine new partnerships, mostly public-private, under the EU's flagship research funding program - Horizon Europe. One of them is the…

actionsantemondiale14 April 2021

Covid-19, Promoting transparent and needs-driven EU R&D policies, Promoting transparent and needs-driven French R&D policies

Over 240 civil society organisations write to WTO Director General

On 13th April, GHA and more than 240 CSOs signed a letter addressed to Director General of the World Trade Organisation Dr. Ngozi Okonjo-Iweala, calling…

actionsantemondiale13 April 2021

Joint CSO Letter on SUPPORTING THE PROPOSAL TO A WAIVER FROM CERTAIN PROVISIONS UNDER THE TRIPS AGREEMENT DURING THE COVID-19 PANDEMIC

Joint letter

Covid-19, Promoting transparent and needs-driven French R&D policies

Joint CSO Letter on SUPPORTING THE PROPOSAL TO A WAIVER FROM CERTAIN PROVISIONS UNDER THE TRIPS AGREEMENT DURING THE COVID-19 PANDEMIC

Aligned with our first support through the open letter signed by more than 500 organisations, GHA and more than 100 civil society organisations are now…

@dm1n1str@t0r19 November 2020

Civil society launches shadow EU global health strategy in light of the COVID-19 pandemic

Press release

Cooperation for development EU, Covid-19

Civil society launches shadow EU global health strategy in light of the COVID-19 pandemic

If the COVID-19 pandemic could teach us just one lesson, let it be that we - the international community - must be better prepared to…

@dm1n1str@t0r24 July 2020

Time to use EU Research funds for better purposes than industry-controlled PPPs

Open letter

Promoting transparent and needs-driven French R&D policies

Time to use EU Research funds for better purposes than industry-controlled PPPs

A response to the Innovative Medicines Initiative’s open letter 10/07/2020 On May 25th, Corporate Europe Observatory and Global Health Advocates published two investigative reports on…

@dm1n1str@t0r10 July 2020

Analysis

Cooperation for development EU

International Development and the next EU Budget : An analysis of the European Commission’s proposals on EFSD and EFSD+ in the revised NDICI and Next Generation EU

Noting the special challenges of the COVID-19 global pandemic, GHA welcomes the “Next Generation EU” recovery package, and the revised 7 year budget proposal, which…

@dm1n1str@t0r29 June 2020

Reaction: The EU continues its support for global health

Press release

Cooperation for development EU

Reaction: The EU continues its support for global health

On June 4th, 2020, the UK hosted the replenishment of Gavi, the Vaccine Alliance, providing an the international community to realign with the ambitions of…

@dm1n1str@t0r5 June 2020

Unkept promises on flucytosine : EU research funds for helping people living with HIV in Africa so far appear to have only helped Sanofi’s profits

Focus

Promoting transparent and needs-driven EU R&D policies

Unkept promises on flucytosine : EU research funds for helping people living with HIV in Africa so far appear to have only helped Sanofi’s profits

This article is an updated version of a case study contained in the report "More Private than Public – The ways Big Pharma dominates the Innovative Medicines…

@dm1n1str@t0r3 June 2020

New reports ‘In the name of innovation’ show industry controls billions for EU’s health and climate research

Press release

Promoting transparent and needs-driven EU R&D policies

New reports ‘In the name of innovation’ show industry controls billions for EU’s health and climate research

For the past 15 years, industry lobby groups have controlled the use of €3.6 billion in public EU funds for health and climate research through…

@dm1n1str@t0r25 May 2020

New report : “More private than public: the ways Big Pharma dominates the Innovative Medicines Initiative”

Press release

Promoting transparent and needs-driven EU R&D policies

New report : “More private than public: the ways Big Pharma dominates the Innovative Medicines Initiative”

The report "More private than public: the way Big Pharma dominates the Innovative Medicines Initiative" is part of an in-depth work dedicated to EU’s health…

@dm1n1str@t0r25 May 2020

“Let’s spread solidarity, not the virus” : call to end privatization of health and to achieve Health for All in time of Covid-19

Open-ed

Promoting transparent and needs-driven EU R&D policies

“Let’s spread solidarity, not the virus” : call to end privatization of health and to achieve Health for All in time of Covid-19

On the occasion of the day of action against the commercialisation of health, Global Health Advocates endorsed, with other health CSOs, a statement coordinated by…

@dm1n1str@t0r14 May 2020

Call to EU Commission and donors for concrete actions to result in access for all

Recommendation

Cooperation for development EU, Covid-19

Call to EU Commission and donors for concrete actions to result in access for all

As the global pledging conference will be hosted by the EU Commission today May 4th, Global Health Advocates endorsed, with other health CSOs, a public…

@dm1n1str@t0r4 May 2020

People or Profits: how will the European Parliament vote on vaccine equity?

Global Health Summit / Global Health Advocates reaction to the draft Declaration

A watershed moment in the global fight against the pandemic: so far a strong opponent, now the United States supports the lifting of patents on COVID19 vaccines.

One year anniversary of ACT-Accelerator: How can we guarantee an equitable and efficient response to the global COVID19 crisis?

Nearly 400 MEPs and MPs Join Chorus of Voices Calling for a TRIPS Waiver on COVID-19 Vaccines

Statement of Global Health Advocates for the Global Health Summit: A political landmark for bold progress in the COVID-19 response and achieving global health equity

Innovative Health Initiative – what’s in it for society?

Over 240 civil society organisations write to WTO Director General

Joint CSO Letter on SUPPORTING THE PROPOSAL TO A WAIVER FROM CERTAIN PROVISIONS UNDER THE TRIPS AGREEMENT DURING THE COVID-19 PANDEMIC

Civil society launches shadow EU global health strategy in light of the COVID-19 pandemic

Time to use EU Research funds for better purposes than industry-controlled PPPs

International Development and the next EU Budget : An analysis of the European Commission’s proposals on EFSD and EFSD+ in the revised NDICI and Next Generation EU

Reaction: The EU continues its support for global health

Unkept promises on flucytosine : EU research funds for helping people living with HIV in Africa so far appear to have only helped Sanofi’s profits

New reports ‘In the name of innovation’ show industry controls billions for EU’s health and climate research

New report : “More private than public: the ways Big Pharma dominates the Innovative Medicines Initiative”

“Let’s spread solidarity, not the virus” : call to end privatization of health and to achieve Health for All in time of Covid-19

Call to EU Commission and donors for concrete actions to result in access for all

Adresses

Réseaux sociaux

Contact us